期刊文献+

急性白血病合并DIC临床分析 被引量:1

下载PDF
导出
摘要 目的:探讨急性白血病(acute leukemia AL)患者DIC的诊治特点。方法:对29例AL合并DIC患者进行回顾性分析。结果:并发D1C的AL类型为急性早幼粒细胞白细胞(acute promyelocytic leukemia APL)18例,非APL型急性髓系白血病(ANLL)7例,急性淋巴细胞白血病(ALL)4例,治愈8例,死亡21例。结论:白血病细胞为诱发DIC的主要因素,治疗上需在积极治疗白血病的基础上多种方法联合使用。
作者 方洁
出处 《内蒙古中医药》 2010年第17期20-21,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
  • 相关文献

参考文献6

  • 1Estey EH.Keating MJ.Mc Greadie KB et al.Causes of initial remission induction faiture in aeute myelogenous leukemia.Blood.1982,60:309.
  • 2张之南,沈悌.血液病诊断及疗效标准[M].第3版.北京:科学出版社,2008.232-235.
  • 3沈迪,宋善俊,弥散性血管内凝血[M] ,第1版,上海:上海科学技术出版社,1995,12.
  • 4Bergqvist D.Low molecular weitht heparins[J].J intern Med,1996,240(1):63-72.
  • 5胡豫,王华芳.弥散性血管内凝血诊治进展[J].中国实用内科杂志,2008,28(10):820-823. 被引量:7
  • 6Rodriguez Gomez M,Lopez Fernandez MF,Tne rapy of disse minated intravascular coagulation in acute promyelocytic leukemia:apropos of 19 cases.Sangre,1993,38(6):449.

二级参考文献11

  • 1Dalainas I. Pathogenesis,diag~osis,and management of disseminated intravascular coagulation :a literature review [ J ]. Eur Rev Med Pharmacol Sci,2008,12 ( 1 ) : 19 - 31.
  • 2Taylor JR FB, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation - on behalf of the Scientific Subcommittee on disseminated intravascular coagulation (DIC)of the Interna- tional Society on Thrombosis and Haemostasis(ISTH) [ J]. Thromb Haemost ,2001,86 : 1327 - 1230.
  • 3Levi M, Ten CH. Disseminated intravascular coagulation [ J]. N Engl J Med,1999,341:586 -592.
  • 4Bernard GR, Vincent JL, Laterre PF, et al. Recombinant human Protein C worldwide evaluation in severe sepsis(PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis [ J ]. N Engl J Med ,2001,344:699 -709.
  • 5Abraham E, Laterre PF, Garg R, et al. Administration of drotrecogin Alfa ( activated ) in early stage severe sepsis ( address ) study group. Drotrecogin alfa(activated) for adults with severe sepsis and a low risk of death[J]. N Engl J Med,2005 ,353 :1332 - 1341.
  • 6Kessler CM, Tang Z, Jacobs HM, et al. The suprapharmacological dosing of antithrombin concentrate for Staphylococcus aureus induced disseminated intravascular coagulation in guinea pigs:substantial reduction in mortality and morbidity[ J]. Blood, 1997,89: 4393 - 4401.
  • 7Elsayyed YA, Nakagawa K, Kamikubo YI, et al. Effects of recombinant human tissue factor pathway inhibitor on thrombus formation and its in vivo distribution in a rat DIC model [ J ]. Am J Clin Pathol, 1996,106:574 - 583.
  • 8Abraham E, Reinhart K, Opal S, et al. Optimist Trial Study Group. Efficacy and safety of tifacogin ( recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial [ J]. JAMA,2003,290 : 238 - 247.
  • 9Fujita M, Izutani W, Komurasaki Y. Effect of urinary protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation in rats[ J]. Thromb Haemost,2000,84 ( 1 ) :54 - 58.
  • 10Moscardo F,Perez F,De La RJ,et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VK [ J ]. Br J Haemato1,2001,114 ( 1 ) : 174 - 176.

共引文献59

同被引文献6

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部